113 related articles for article (PubMed ID: 30334447)
1. CtBP2 promotes proliferation and reduces drug sensitivity in non-small cell lung cancer via the Wnt/β-catenin pathway.
Wang DP; Gu LL; Xue Q; Chen H; Mao GX
Neoplasma; 2018 Nov; 65(6):888-897. PubMed ID: 30334447
[TBL] [Abstract][Full Text] [Related]
2. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
[TBL] [Abstract][Full Text] [Related]
3. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
[TBL] [Abstract][Full Text] [Related]
4. C-terminal binding protein-2 promotes cell proliferation and migration in breast cancer via suppression of p16INK4A.
Yang X; Sun Y; Li H; Shao Y; Zhao D; Yu W; Fu J
Oncotarget; 2017 Apr; 8(16):26154-26168. PubMed ID: 28412731
[TBL] [Abstract][Full Text] [Related]
5. ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling.
Vesel M; Rapp J; Feller D; Kiss E; Jaromi L; Meggyes M; Miskei G; Duga B; Smuk G; Laszlo T; Karner I; Pongracz JE
Respir Res; 2017 Mar; 18(1):52. PubMed ID: 28340578
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/β-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma.
Chen H; Zhang M; Zhang W; Li Y; Zhu J; Zhang X; Zhao L; Zhu S; Chen B
Thorac Cancer; 2018 Mar; 9(3):390-399. PubMed ID: 29341468
[TBL] [Abstract][Full Text] [Related]
7. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
[TBL] [Abstract][Full Text] [Related]
8. High Kpnβ1 expression promotes non-small cell lung cancer proliferation and chemoresistance via the PI3-kinase/AKT pathway.
Wang H; Wang D; Li C; Zhang X; Zhou X; Huang J
Tissue Cell; 2018 Apr; 51():39-48. PubMed ID: 29622086
[TBL] [Abstract][Full Text] [Related]
9. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
10. EPB41 suppresses the Wnt/β-catenin signaling in non-small cell lung cancer by sponging ALDOC.
Yuan J; Xing H; Li Y; Song Y; Zhang N; Xie M; Liu J; Xu Y; Shen Y; Wang B; Zhang L; Yang M
Cancer Lett; 2021 Feb; 499():255-264. PubMed ID: 33242559
[TBL] [Abstract][Full Text] [Related]
11. Wnt signaling pathway in non-small cell lung cancer.
Stewart DJ
J Natl Cancer Inst; 2014 Jan; 106(1):djt356. PubMed ID: 24309006
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of HIF-2α-Dependent NEAT1 Promotes the Progression of Non-Small Cell Lung Cancer through miR-101-3p/SOX9/Wnt/β-Catenin Signal Pathway.
Kong X; Zhao Y; Li X; Tao Z; Hou M; Ma H
Cell Physiol Biochem; 2019; 52(3):368-381. PubMed ID: 30845377
[TBL] [Abstract][Full Text] [Related]
13. Silence of fibronectin 1 increases cisplatin sensitivity of non-small cell lung cancer cell line.
Gao W; Liu Y; Qin R; Liu D; Feng Q
Biochem Biophys Res Commun; 2016 Jul; 476(1):35-41. PubMed ID: 27207836
[TBL] [Abstract][Full Text] [Related]
14. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
[TBL] [Abstract][Full Text] [Related]
15. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
[TBL] [Abstract][Full Text] [Related]
16. HES5 promotes cellular proliferation of non-small cell lung cancer through STAT3 signaling.
Gu S; Zhang R; Gu J; Li X; Lv L; Jiang J; Xu Z; Wang S; Shi C; Wang DP; Wu C
Oncol Rep; 2017 Jan; 37(1):474-482. PubMed ID: 27878283
[TBL] [Abstract][Full Text] [Related]
17. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
Zhang Y; Zhang Q; Chen H; Wang C
Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
[TBL] [Abstract][Full Text] [Related]
18. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
Yang S; Liu Y; Li MY; Ng CSH; Yang SL; Wang S; Zou C; Dong Y; Du J; Long X; Liu LZ; Wan IYP; Mok T; Underwood MJ; Chen GG
Mol Cancer; 2017 Jul; 16(1):124. PubMed ID: 28716029
[TBL] [Abstract][Full Text] [Related]
19. C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.
Shi H; Mao Y; Ju Q; Wu Y; Bai W; Wang P; Zhang Y; Jiang M
Int J Oncol; 2018 Jul; 53(1):167-176. PubMed ID: 29658564
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
